Advances in Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease: 2nd Edition
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: 31 August 2026 | Viewed by 3
Special Issue Editor
Interests: STEMI; platelet and antiplatelet therapies; coronary stenting; genetic polymorphisms; atherosclerosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We sincerely invite you to contribute to this Special Issue "Advances in Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease: 2nd Edition". The first edition is available at https://www.mdpi.com/journal/jcm/special_issues/4ZNJ8HNECK. This Special Issue combines original research and review papers with a focus on the recent advances in coronary artery disease.
Coronary artery disease (CAD) is one of the most significant threats to cardiovascular health, and the selection and optimization of antithrombotic therapy remains a core challenge in clinical practice. Antiplatelet therapy, represented by aspirin and P2Y12 receptor antagonists, is the cornerstone of secondary prevention of CAD and post-percutaneous coronary intervention (PCI) management. However, increasingly complex situations arise in clinical practice, particularly in patients with CAD complicated by atrial fibrillation who require long-term oral anticoagulation after stent placement. Balancing anticoagulation and antiplatelet therapy has become a thorny issue. Treatment for these patients requires reducing the risk of in-stent thrombosis, stroke, and other ischemic events while strictly preventing serious complications such as gastrointestinal or intracranial hemorrhage.
In recent years, with the accumulation of evidence regarding the use of new drugs and the continuous refinement of treatment strategies, clinical guidelines have been continuously updated, providing a clearer path for the individualized management of these high-risk patients. This Special Issue aims to gather the latest research progress and clinical practice experience in this field, focusing on key issues such as antithrombotic strategy selection, treatment course formulation, risk assessment, and complication prevention for patients with acute coronary syndrome and those undergoing PCI with anticoagulation indications. We welcome original research and review articles to jointly update and promote the progress of antithrombotic therapy for coronary artery disease.
Prof. Dr. Giuseppe De Luca
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- platelet
- anticoagulant therapy
- antiplatelet therapy
- coronary artery disease (CAD)
- atrial fibrillation (AF)
- thromboembolic events
- myocardial ischemic
- bleeding events
- aspirin
- clopidogrel
- cardiovascular and cerebrovascular diseases
- diagnosis and treatment
- percutaneous coronary intervention
- acute coronary syndrome
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
